Annual EBITDA
$3.08 B
+$331.00 M+12.05%
31 December 2023
Summary:
Boston Scientific annual earnings before interest, taxes, depreciation & amortization is currently $3.08 billion, with the most recent change of +$331.00 million (+12.05%) on 31 December 2023. During the last 3 years, it has risen by +$1.67 billion (+119.07%). BSX annual EBITDA is now at all-time high.BSX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
$953.00 M
+$145.00 M+17.95%
30 September 2024
Summary:
Boston Scientific quarterly earnings before interest, taxes, depreciation & amortization is currently $953.00 million, with the most recent change of +$145.00 million (+17.95%) on 30 September 2024. Over the past year, it has dropped by -$23.00 million (-2.36%). BSX quarterly EBITDA is now -2.85% below its all-time high of $981.00 million, reached on 31 March 2024.BSX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
$3.63 B
-$23.00 M-0.63%
30 September 2024
Summary:
Boston Scientific TTM earnings before interest, taxes, depreciation & amortization is currently $3.63 billion, with the most recent change of -$23.00 million (-0.63%) on 30 September 2024. Over the past year, it has increased by +$307.00 million (+9.25%). BSX TTM EBITDA is now -0.63% below its all-time high of $3.65 billion, reached on 30 June 2024.BSX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BSX EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +12.1% | -2.4% | +9.3% |
| 3 y3 years | +119.1% | +13.3% | +34.0% |
| 5 y5 years | +20.4% | +161.8% | +80.6% |
BSX EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +119.1% | -2.9% | +92.1% | -0.6% | +45.6% |
| 5 y | 5 years | at high | +119.1% | -2.9% | +575.9% | -0.6% | +233.5% |
| alltime | all time | at high | +197.3% | -2.9% | +127.6% | -0.6% | +191.5% |
Boston Scientific EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $953.00 M(+17.9%) | $3.63 B(-0.6%) |
| June 2024 | - | $808.00 M(-17.6%) | $3.65 B(+0.4%) |
| Mar 2024 | - | $981.00 M(+11.1%) | $3.63 B(+5.4%) |
| Dec 2023 | $3.08 B(+12.0%) | $883.00 M(-9.5%) | $3.45 B(+3.9%) |
| Sept 2023 | - | $976.00 M(+22.9%) | $3.32 B(+13.1%) |
| June 2023 | - | $794.00 M(0.0%) | $2.93 B(+3.6%) |
| Mar 2023 | - | $794.00 M(+5.3%) | $2.83 B(+3.1%) |
| Dec 2022 | $2.75 B(+9.4%) | $754.00 M(+27.4%) | $2.75 B(+10.4%) |
| Sept 2022 | - | $592.00 M(-14.6%) | $2.49 B(-9.1%) |
| June 2022 | - | $693.00 M(-2.3%) | $2.74 B(+7.7%) |
| Mar 2022 | - | $709.00 M(+42.9%) | $2.54 B(+1.4%) |
| Dec 2021 | $2.51 B(+78.6%) | $496.00 M(-41.0%) | $2.51 B(-7.2%) |
| Sept 2021 | - | $841.00 M(+68.9%) | $2.71 B(+34.9%) |
| June 2021 | - | $498.00 M(-26.2%) | $2.01 B(+18.5%) |
| Mar 2021 | - | $675.00 M(-2.5%) | $1.69 B(+20.5%) |
| Dec 2020 | $1.41 B(-35.3%) | $692.00 M(+390.8%) | $1.41 B(+29.3%) |
| Sept 2020 | - | $141.00 M(-23.8%) | $1.09 B(-17.0%) |
| June 2020 | - | $185.00 M(-52.2%) | $1.31 B(-13.8%) |
| Mar 2020 | - | $387.00 M(+3.5%) | $1.52 B(-18.2%) |
| Dec 2019 | $2.17 B(-15.1%) | $374.00 M(+2.7%) | $1.86 B(-7.4%) |
| Sept 2019 | - | $364.00 M(-7.8%) | $2.01 B(-12.9%) |
| June 2019 | - | $395.00 M(-45.6%) | $2.31 B(-6.3%) |
| Mar 2019 | - | $726.00 M(+39.1%) | $2.46 B(+8.9%) |
| Dec 2018 | $2.56 B(+27.5%) | $522.00 M(-21.1%) | $2.26 B(+4.5%) |
| Sept 2018 | - | $662.00 M(+20.1%) | $2.16 B(+7.8%) |
| June 2018 | - | $551.00 M(+5.0%) | $2.01 B(+14.9%) |
| Mar 2018 | - | $525.00 M(+23.5%) | $1.75 B(+1.2%) |
| Dec 2017 | $2.01 B(+63.8%) | $425.00 M(-15.8%) | $1.73 B(+8.9%) |
| Sept 2017 | - | $505.00 M(+73.5%) | $1.58 B(+3.5%) |
| June 2017 | - | $291.00 M(-42.4%) | $1.53 B(+47.6%) |
| Mar 2017 | - | $505.00 M(+77.8%) | $1.04 B(+8.6%) |
| Dec 2016 | $1.23 B(+204.0%) | $284.00 M(-37.0%) | $955.00 M(+81.6%) |
| Sept 2016 | - | $451.00 M(-322.2%) | $526.00 M(-610.7%) |
| June 2016 | - | -$203.00 M(-148.0%) | -$103.00 M(-124.1%) |
| Mar 2016 | - | $423.00 M(-391.7%) | $427.00 M(+238.9%) |
| Dec 2015 | $403.00 M(-6.7%) | -$145.00 M(-18.5%) | $126.00 M(-207.7%) |
| Sept 2015 | - | -$178.00 M(-154.4%) | -$117.00 M(-151.5%) |
| June 2015 | - | $327.00 M(+168.0%) | $227.00 M(-640.5%) |
| Mar 2015 | - | $122.00 M(-131.4%) | -$42.00 M(-129.0%) |
| Dec 2014 | $432.00 M(-45.3%) | -$388.00 M(-333.7%) | $145.00 M(-80.8%) |
| Sept 2014 | - | $166.00 M(+186.2%) | $755.00 M(-4.1%) |
| June 2014 | - | $58.00 M(-81.2%) | $787.00 M(-24.8%) |
| Mar 2014 | - | $309.00 M(+39.2%) | $1.05 B(+104.5%) |
| Dec 2013 | $790.00 M(-125.0%) | $222.00 M(+12.1%) | $512.00 M(+1.0%) |
| Sept 2013 | - | $198.00 M(-37.7%) | $507.00 M(-366.8%) |
| June 2013 | - | $318.00 M(-240.7%) | -$190.00 M(-95.2%) |
| Mar 2013 | - | -$226.00 M(-204.1%) | -$3.96 B(+14.9%) |
| Dec 2012 | -$3.16 B(-292.9%) | $217.00 M(-143.5%) | -$3.45 B(+1.5%) |
| Sept 2012 | - | -$499.00 M(-85.6%) | -$3.40 B(+29.3%) |
| June 2012 | - | -$3.46 B(-1295.5%) | -$2.63 B(-328.0%) |
| Mar 2012 | - | $289.00 M(+8.2%) | $1.15 B(-14.2%) |
| Dec 2011 | $1.64 B(+1023.3%) | $267.00 M(-1.1%) | $1.34 B(-13.0%) |
| Sept 2011 | - | $270.00 M(-17.4%) | $1.54 B(-6.8%) |
| June 2011 | - | $327.00 M(-31.9%) | $1.66 B(-1.1%) |
| Mar 2011 | - | $480.00 M(+2.6%) | $1.68 B(-1168.2%) |
| Dec 2010 | $146.00 M(-317.9%) | $468.00 M(+22.2%) | -$157.00 M(-90.9%) |
| Sept 2010 | - | $383.00 M(+10.7%) | -$1.72 B(-10.9%) |
| June 2010 | - | $346.00 M(-125.6%) | -$1.93 B(+2.8%) |
| Mar 2010 | - | -$1.35 B(+23.7%) | -$1.88 B(+380.3%) |
| Dec 2009 | -$67.00 M(-90.4%) | -$1.09 B(-732.9%) | -$391.00 M(-75.3%) |
| Sept 2009 | - | $173.00 M(-56.5%) | -$1.58 B(+0.1%) |
| June 2009 | - | $398.00 M(+199.2%) | -$1.58 B(+4.4%) |
| Mar 2009 | - | $133.00 M(-105.8%) | -$1.51 B(+33.8%) |
| Dec 2008 | -$699.00 M(-176.1%) | -$2.29 B(-1405.7%) | -$1.13 B(-237.9%) |
| Sept 2008 | - | $175.00 M(-62.3%) | $820.00 M(+12.6%) |
| June 2008 | - | $464.00 M(-9.9%) | $728.00 M(+4.9%) |
| Mar 2008 | - | $515.00 M(-254.2%) | $694.00 M(+12.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2007 | $919.00 M(-52.9%) | -$334.00 M(-502.4%) | $616.00 M(-56.3%) |
| Sept 2007 | - | $83.00 M(-80.7%) | $1.41 B(-15.8%) |
| June 2007 | - | $430.00 M(-1.6%) | $1.68 B(+4.6%) |
| Mar 2007 | - | $437.00 M(-5.0%) | $1.60 B(-5.8%) |
| Dec 2006 | $1.95 B(+25.2%) | $460.00 M(+32.2%) | $1.70 B(-2.5%) |
| Sept 2006 | - | $348.00 M(-2.5%) | $1.74 B(+57.6%) |
| June 2006 | - | $357.00 M(-33.3%) | $1.11 B(-15.8%) |
| Mar 2006 | - | $535.00 M(+6.4%) | $1.31 B(-5.9%) |
| Dec 2005 | $1.56 B(-18.6%) | $503.00 M(-274.0%) | $1.40 B(-2.2%) |
| Sept 2005 | - | -$289.00 M(-151.2%) | $1.43 B(-32.3%) |
| June 2005 | - | $565.00 M(-8.4%) | $2.11 B(+1.3%) |
| Mar 2005 | - | $617.00 M(+15.3%) | $2.08 B(+18.9%) |
| Dec 2004 | $1.91 B(+105.8%) | $535.00 M(+36.5%) | $1.75 B(+21.3%) |
| Sept 2004 | - | $392.00 M(-27.1%) | $1.44 B(+15.2%) |
| June 2004 | - | $538.00 M(+88.1%) | $1.25 B(+36.0%) |
| Mar 2004 | - | $286.00 M(+26.0%) | $921.00 M(+11.9%) |
| Dec 2003 | $930.00 M(+8.6%) | $227.00 M(+12.4%) | $823.00 M(+1.4%) |
| Sept 2003 | - | $202.00 M(-1.9%) | $812.00 M(-7.2%) |
| June 2003 | - | $206.00 M(+9.6%) | $875.00 M(+7.6%) |
| Mar 2003 | - | $188.00 M(-13.0%) | $813.00 M(+6.0%) |
| Dec 2002 | $856.00 M(+39.4%) | $216.00 M(-18.5%) | $767.00 M(-20.8%) |
| Sept 2002 | - | $265.00 M(+84.0%) | $968.00 M(+15.9%) |
| June 2002 | - | $144.00 M(+1.4%) | $835.00 M(+6.4%) |
| Mar 2002 | - | $142.00 M(-65.9%) | $785.00 M(0.0%) |
| Dec 2001 | $614.00 M(-28.3%) | $417.00 M(+215.9%) | $785.00 M(+27.0%) |
| Sept 2001 | - | $132.00 M(+40.4%) | $618.00 M(-8.3%) |
| June 2001 | - | $94.00 M(-33.8%) | $674.00 M(-15.2%) |
| Mar 2001 | - | $142.00 M(-43.2%) | $795.00 M(-7.1%) |
| Dec 2000 | $856.00 M(-5.2%) | $250.00 M(+33.0%) | $856.00 M(+7.0%) |
| Sept 2000 | - | $188.00 M(-12.6%) | $800.00 M(+9.7%) |
| June 2000 | - | $215.00 M(+5.9%) | $729.00 M(-3.1%) |
| Mar 2000 | - | $203.00 M(+4.6%) | $752.00 M(-2.5%) |
| Dec 1999 | $903.00 M(+45.6%) | $194.00 M(+65.8%) | $771.00 M(-8.2%) |
| Sept 1999 | - | $117.00 M(-50.8%) | $840.00 M(-1.5%) |
| June 1999 | - | $238.00 M(+7.2%) | $853.00 M(+16.7%) |
| Mar 1999 | - | $222.00 M(-15.6%) | $731.00 M(+17.9%) |
| Dec 1998 | $620.00 M(+21.8%) | $263.00 M(+102.3%) | $620.00 M(+53.9%) |
| Sept 1998 | - | $130.00 M(+12.1%) | $402.80 M(+1.4%) |
| June 1998 | - | $116.00 M(+4.5%) | $397.30 M(-5.4%) |
| Mar 1998 | - | $111.00 M(+142.4%) | $420.10 M(-0.4%) |
| Dec 1997 | $509.00 M(+23.6%) | $45.80 M(-63.2%) | $421.90 M(+8.3%) |
| Sept 1997 | - | $124.50 M(-10.3%) | $389.50 M(+4.1%) |
| June 1997 | - | $138.80 M(+23.0%) | $374.10 M(+6.6%) |
| Mar 1997 | - | $112.80 M(+741.8%) | $350.90 M(+16.0%) |
| Dec 1996 | $411.80 M(+37.3%) | $13.40 M(-87.7%) | $302.50 M(-4.8%) |
| Sept 1996 | - | $109.10 M(-5.6%) | $317.60 M(+10.6%) |
| June 1996 | - | $115.60 M(+79.5%) | $287.20 M(+16.4%) |
| Mar 1996 | - | $64.40 M(+126.0%) | $246.80 M(-3.8%) |
| Dec 1995 | $299.90 M(+115.8%) | $28.50 M(-63.8%) | $256.60 M(-3.5%) |
| Sept 1995 | - | $78.70 M(+4.7%) | $265.90 M(+21.4%) |
| June 1995 | - | $75.20 M(+1.3%) | $219.00 M(+25.5%) |
| Mar 1995 | - | $74.20 M(+96.3%) | $174.50 M(+34.2%) |
| Dec 1994 | $139.00 M(+20.9%) | $37.80 M(+18.9%) | $130.00 M(+3.1%) |
| Sept 1994 | - | $31.80 M(+3.6%) | $126.10 M(+2.8%) |
| June 1994 | - | $30.70 M(+3.4%) | $122.70 M(+2.6%) |
| Mar 1994 | - | $29.70 M(-12.4%) | $119.60 M(+4.1%) |
| Dec 1993 | $115.00 M(+18.1%) | $33.90 M(+19.4%) | $114.90 M(+6.7%) |
| Sept 1993 | - | $28.40 M(+2.9%) | $107.70 M(+2.7%) |
| June 1993 | - | $27.60 M(+10.4%) | $104.90 M(+4.4%) |
| Mar 1993 | - | $25.00 M(-6.4%) | $100.50 M(+3.1%) |
| Dec 1992 | $97.40 M(+31.8%) | $26.70 M(+4.3%) | $97.50 M(-491.6%) |
| Sept 1992 | - | $25.60 M(+10.3%) | -$24.90 M(-364.9%) |
| June 1992 | - | $23.20 M(+5.5%) | $9.40 M(-77.7%) |
| Mar 1992 | - | $22.00 M(-123.0%) | $42.10 M(-40.4%) |
| Dec 1991 | $73.90 M | -$95.70 M(-259.8%) | $70.60 M(-57.5%) |
| Sept 1991 | - | $59.90 M(+7.2%) | $166.30 M(+56.3%) |
| June 1991 | - | $55.90 M(+10.7%) | $106.40 M(+110.7%) |
| Mar 1991 | - | $50.50 M | $50.50 M |
FAQ
- What is Boston Scientific annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Boston Scientific?
- What is Boston Scientific annual EBITDA year-on-year change?
- What is Boston Scientific quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Boston Scientific?
- What is Boston Scientific quarterly EBITDA year-on-year change?
- What is Boston Scientific TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Boston Scientific?
- What is Boston Scientific TTM EBITDA year-on-year change?
What is Boston Scientific annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of BSX is $3.08 B
What is the all time high annual EBITDA for Boston Scientific?
Boston Scientific all-time high annual earnings before interest, taxes, depreciation & amortization is $3.08 B
What is Boston Scientific annual EBITDA year-on-year change?
Over the past year, BSX annual earnings before interest, taxes, depreciation & amortization has changed by +$331.00 M (+12.05%)
What is Boston Scientific quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of BSX is $953.00 M
What is the all time high quarterly EBITDA for Boston Scientific?
Boston Scientific all-time high quarterly earnings before interest, taxes, depreciation & amortization is $981.00 M
What is Boston Scientific quarterly EBITDA year-on-year change?
Over the past year, BSX quarterly earnings before interest, taxes, depreciation & amortization has changed by -$23.00 M (-2.36%)
What is Boston Scientific TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of BSX is $3.63 B
What is the all time high TTM EBITDA for Boston Scientific?
Boston Scientific all-time high TTM earnings before interest, taxes, depreciation & amortization is $3.65 B
What is Boston Scientific TTM EBITDA year-on-year change?
Over the past year, BSX TTM earnings before interest, taxes, depreciation & amortization has changed by +$307.00 M (+9.25%)